• Something wrong with this record ?

Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia

J. Kminkova, M. Mraz, K. Zaprazna, V. Navrkalova, B. Tichy, K. Plevova, J. Malcikova, K. Cerna, T. Rausch, V. Benes, Y. Brychtova, M. Doubek, J. Mayer, S. Pospisilova,

. 2014 ; 35 (5) : 992-1002.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT11218 MZ0 CEP Register
NT13493 MZ0 CEP Register

MicroRNA (miRNA) expression is deregulated in many tumors including chronic lymphocytic leukemia (CLL). Although the particular mechanism(s) responsible for their aberrant expression is not well characterized, the presence of mutations and single-nucleotide polymorphisms (SNPs) in miRNA genes, possibly affecting their secondary structure and expression, has been described. In CLL; however, the impact and frequency of such variations have yet to be elucidated. Using a custom resequencing microarray, we screened sequence variations in 109 cancer-related pre-miRNAs in 98 CLL patients. Additionally, the primary regions of miR-29b-2/29c and miR-16-1 were analyzed by Sanger sequencing in another cohort of 213 and 193 CLL patients, respectively. Altogether, we describe six novel miR-sequence variations and the presence of SNPs (n = 27), most of which changed the miR-secondary structure. Moreover, some of the identified SNPs have a significantly different frequency in CLL when compared with a control population. Additionally, we identified a novel variation in miR-16-1 that had not been described previously in CLL patients. We show that this variation affects the expression of mature miR-16-1. We also show that the expression of another miRNA with pathogenetic relevance for CLL, namely miR-29b-2, is influenced by the presence of a polymorphic insertion, which is more frequent in CLL than in a control population. Altogether, these data suggest that sequence variations may occur during CLL development and/or progression.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14063824
003      
CZ-PrNML
005      
20240103120850.0
007      
ta
008      
140704s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/carcin/bgt396 $2 doi
035    __
$a (PubMed)24306027
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kminkova, Jana $u CEITEC - Central European Institute of Technology, Center of Molecular Medicine, Masaryk University, Brno 625 00, Czech Republic.
245    10
$a Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia / $c J. Kminkova, M. Mraz, K. Zaprazna, V. Navrkalova, B. Tichy, K. Plevova, J. Malcikova, K. Cerna, T. Rausch, V. Benes, Y. Brychtova, M. Doubek, J. Mayer, S. Pospisilova,
520    9_
$a MicroRNA (miRNA) expression is deregulated in many tumors including chronic lymphocytic leukemia (CLL). Although the particular mechanism(s) responsible for their aberrant expression is not well characterized, the presence of mutations and single-nucleotide polymorphisms (SNPs) in miRNA genes, possibly affecting their secondary structure and expression, has been described. In CLL; however, the impact and frequency of such variations have yet to be elucidated. Using a custom resequencing microarray, we screened sequence variations in 109 cancer-related pre-miRNAs in 98 CLL patients. Additionally, the primary regions of miR-29b-2/29c and miR-16-1 were analyzed by Sanger sequencing in another cohort of 213 and 193 CLL patients, respectively. Altogether, we describe six novel miR-sequence variations and the presence of SNPs (n = 27), most of which changed the miR-secondary structure. Moreover, some of the identified SNPs have a significantly different frequency in CLL when compared with a control population. Additionally, we identified a novel variation in miR-16-1 that had not been described previously in CLL patients. We show that this variation affects the expression of mature miR-16-1. We also show that the expression of another miRNA with pathogenetic relevance for CLL, namely miR-29b-2, is influenced by the presence of a polymorphic insertion, which is more frequent in CLL than in a control population. Altogether, these data suggest that sequence variations may occur during CLL development and/or progression.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a alely $7 D000483
650    _2
$a chromozomální aberace $7 D002869
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese u leukemie $7 D015973
650    _2
$a frekvence genu $7 D005787
650    12
$a genetická variace $7 D014644
650    _2
$a zárodečné mutace $7 D018095
650    _2
$a lidé $7 D006801
650    _2
$a těžké řetězce imunoglobulinů $x genetika $7 D007143
650    _2
$a chronická lymfatická leukemie $x genetika $7 D015451
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x chemie $x genetika $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mutace $7 D009154
650    _2
$a konformace nukleové kyseliny $7 D009690
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a sekvenční analýza DNA $7 D017422
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mráz, Marek $7 xx0122131
700    1_
$a Zápražná, Kristína $7 xx0231086
700    1_
$a Navrkalová, Veronika $7 mub2014808711
700    1_
$a Tichý, Boris $7 xx0312236
700    1_
$a Plevová, Karla $7 xx0158852
700    1_
$a Malčíková, Jitka, $d 1979- $7 mub2011655946
700    1_
$a Černá, Kateřina $7 xx0258259
700    1_
$a Rausch, Tobias
700    1_
$a Beneš, Vladimír $7 xx0244154
700    1_
$a Brychtová, Yvona $7 xx0105542
700    1_
$a Doubek, Michael, $d 1972- $7 mzk2004217554
700    1_
$a Mayer, Jiří, $d 1960- $7 nlk20000083651
700    1_
$a Pospíšilová, Šárka, $d 1969- $7 xx0101843
773    0_
$w MED00001050 $t Carcinogenesis $x 1460-2180 $g Roč. 35, č. 5 (2014), s. 992-1002
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24306027 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20240103120846 $b ABA008
999    __
$a ok $b bmc $g 1031308 $s 862556
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 35 $c 5 $d 992-1002 $i 1460-2180 $m Carcinogenesis $n Carcinogenesis $x MED00001050
GRA    __
$a NT11218 $p MZ0
GRA    __
$a NT13493 $p MZ0
LZP    __
$a Pubmed-20140704

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...